CJ Corporation

CJ Corporation is a major South Korean conglomerate with significant activities in life sciences through its pharmaceutical and biotech arms. Its subsidiary companies have developed antibiotics, vaccines—including one of the world’s first alpha-interferon drugs—and are now global leaders in microbiome-based therapeutics R&D. The group leverages advanced bioinformatics platforms for both diagnostics and therapeutic development. Clinical results from recent years include ongoing multinational trials targeting solid tumors with live biotherapeutic products/microbiome therapies; historical success includes commercialization of vaccines like Hepaccine-B against hepatitis B.